关注
Sandra Oloketuyi
Sandra Oloketuyi
在 cam.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Chitosan and their derivatives: Antibiofilm drugs against pathogenic bacteria
F Khan, DTN Pham, SF Oloketuyi, P Manivasagan, J Oh, YM Kim
Colloids and Surfaces B: Biointerfaces 185, 110627, 2020
1822020
Diversity of bacterial synthesis of silver nanoparticles
A Javaid, SF Oloketuyi, MM Khan, F Khan
BioNanoScience 8, 43-59, 2018
1282018
Inhibition strategies of Listeria monocytogenes biofilms—current knowledge and future outlooks
SF Oloketuyi, F Khan
Journal of basic microbiology 57 (9), 728-743, 2017
642017
Regulation and controlling the motility properties of Pseudomonas aeruginosa
F Khan, DTN Pham, SF Oloketuyi, YM Kim
Applied microbiology and biotechnology 104, 33-49, 2020
622020
Electrochemical immunosensor functionalized with nanobodies for the detection of the toxic microalgae Alexandrium minutum using glassy carbon electrode modified with gold …
S Oloketuyi, E Mazzega, J Zavašnik, K Pungjunun, K Kalcher, A De Marco, ...
Biosensors and Bioelectronics 154, 112052, 2020
472020
Strategies for Biofilm Inhibition and Virulence Attenuation of Foodborne Pathogen-Escherichia coli O157:H7
SF Oloketuyi, F Khan
Current microbiology 74, 1477-1489, 2017
452017
Bacteria and bacterial products: Foe and friends to Caenorhabditis elegans
F Khan, S Jain, SF Oloketuyi
Microbiological research 215, 102-113, 2018
442018
Treatment strategies targeting persister cell formation in bacterial pathogens
F Khan, DTN Pham, N Tabassum, SF Oloketuyi, YM Kim
Critical reviews in microbiology 46 (6), 665-688, 2020
352020
Diversity of bacteria and bacterial products as antibiofilm and antiquorum sensing drugs against pathogenic bacteria
F Khan, SF Oloketuyi, YM Kim
Current drug targets 20 (11), 1156-1179, 2019
302019
A framework for evaluating the performance of SMLM cluster analysis algorithms
DJ Nieves, JA Pike, F Levet, DJ Williamson, M Baragilly, S Oloketuyi, ...
Nature methods 20 (2), 259-267, 2023
292023
Antibiotics application strategies to control biofilm formation in pathogenic bacteria
F Khan, DTN Pham, SF Oloketuyi, YM Kim
Current pharmaceutical biotechnology 21 (4), 270-286, 2020
252020
A future perspective on neurodegenerative diseases: nasopharyngeal and gut microbiota
F Khan, SF Oloketuyi
Journal of applied microbiology 122 (2), 306-320, 2017
232017
Effect of humanizing mutations on the stability of the llama single-domain variable region
MA Soler, B Medagli, J Wang, S Oloketuyi, G Bajc, H Huang, S Fortuna, ...
Biomolecules 11 (2), 163, 2021
182021
Native llama nanobody library panning performed by phage and yeast display provides binders suitable for C-reactive protein detection
S Oloketuyi, R Bernedo, A Christmann, J Borkowska, G Cazzaniga, ...
Biosensors 11 (12), 496, 2021
132021
Molecules involved in motility regulation in Escherichia coli cells: a review
F Khan, N Tabassum, DTN Pham, SF Oloketuyi, YM Kim
Biofouling 36 (8), 889-908, 2020
132020
Antimicrobial Efficacy and Phytochemical Screening of Mushrooms, Lenzites Betulinus, and Coriolopsis Gallica Extracts.
S Fakoya, S Folarin Oloketuyi
TAF Preventive Medicine Bulletin 11 (6), 2012
132012
Nanobody-Dependent Detection of Microcystis aeruginosa by ELISA and Thermal Lens Spectrometry
OG Folorunsho, SF Oloketuyi, E Mazzega, H Budasheva, A Beran, ...
Applied biochemistry and biotechnology 193, 2729-2741, 2021
122021
A compact nanobody-DNAzyme conjugate enables antigen detection and signal amplification
G Bernardinelli, S Oloketuyi, SF Werner, E Mazzega, B Högberg, ...
New biotechnology 56, 1-8, 2020
122020
An anti-HER2 nanobody binds to its antigen HER2 via two independent paratopes
D Ubbiali, M Orlando, M Kovačič, C Iacobucci, MS Semrau, G Bajc, ...
International journal of biological macromolecules 182, 502-511, 2021
92021
Antibacterial activity of seed extracts of Okra (Abelmoschus esculentus) against selected pathogen
S Oloketuyi
Research & Reviews: Journal of Food Science and Technology 1 (6), 2017
92017
系统目前无法执行此操作,请稍后再试。
文章 1–20